Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Junichiro Sageshima

Transplant Surgery Sacramento, CA Medical Doctor

NPI 1376641258 CMS profile 971919

2221 Stockton Blvd, Cypress Transplant Surgery, Suite B, Sacramento, CA 95817

Open in the dashboard

General payments

$3,045

14 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,137 paid to institutions, not to them · program year 2025

Through program year 2025, Junichiro Sageshima of Sacramento, CA is reported in the CMS Open Payments database as having received $3,045 across 14 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $10,137 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 57th percentile of Transplant Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,058 3
2023 General $758 5
2022 General $1,230 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Junichiro Sageshima
  • Transplant Surgery median
  • Middle half of Transplant Surgery
  • National median

In program year 2025, general payments to Junichiro Sageshima were reported at $1,058. Among 555 Transplant Surgery profiles paid that year, the median was $421 and the middle half received between $116 and $2,169.

Show as a table
Year Junichiro Sageshima Transplant Surgery median Middle half National median
2019 $0 $203 $77–$1,249 $163
2020 $0 $149 $52–$1,366 $114
2021 $0 $168 $73–$2,008 $132
2022 $1,230 $213 $94–$1,464 $149
2023 $758 $262 $93–$1,458 $160
2024 $0 $354 $126–$2,252 $164
2025 $1,058 $421 $116–$2,169 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Intuitive Surgical, Inc. $2,921 13 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $124 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $1,811 8 payments
  2. Education $1,000 1 payment
  3. Food and Beverage $234 5 payments
Products named General payments · program years 2022–2025
  1. Da Vinci Surgical System $1,921 12 payments
  2. DAVINCI XI $1,000 1 payment
  3. LIVTENCITY $124 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$140,984

Medicare's payments for the services billed

Medicare patients

147

Average age 59

Services billed

384

56 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 75%
Diabetes 62%
Heart failure 51%
Ischemic heart disease 45%
Arthritis 27%
Depression 25%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

14 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Transplant Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record